Loading...
•
Apr 30, 2022
Cooper Q2 2022 Earnings Report
Reported a revenue increase of 15% year-over-year, with strong growth in both CooperVision and CooperSurgical segments.
Key Takeaways
CooperCompanies announced strong second quarter results with revenue up 15% year-over-year to $829.8 million. Both CooperVision and CooperSurgical showed strong revenue growth. GAAP diluted earnings per share increased to $2.55, while non-GAAP diluted earnings per share decreased to $3.24.
Revenue increased 15% year-over-year to $829.8 million.
CooperVision revenue was up 6% to $553.8 million.
CooperSurgical revenue was up 40% to $276.0 million.
GAAP diluted earnings per share increased to $2.55, up from $2.36 last year.
Cooper
Cooper
Cooper Revenue by Segment
Cooper Revenue by Geographic Location
Revenue by Segment
Office & Surgical Revenue
CapyFin.comFertility Revenue
CapyFin.comRevenue by Geographic Location
Americas Revenue
CapyFin.comEMEA Revenue
CapyFin.comAsia Pacific Revenue
CapyFin.com Forward Guidance
The Company updated its fiscal year 2022 financial guidance.
Positive Outlook
- Fiscal 2022 total revenue $3,280 - $3,312 million (organic growth of 9% to 10%)
- CVI revenue $2,225 - $2,247 million (organic growth of 10% to 11%)
- CSI revenue $1,055 - $1,065 million (organic growth of 6% to 7%)
- Fiscal 2022 non-GAAP diluted EPS $13.09 - $13.29
- Assumes a 50 basis point rate increase in both June and July and a 25 basis point rate increase in September
Revenue & Expenses
Visualization of income flow from segment revenue to net income